Literature DB >> 23143243

Purification, crystallization and preliminary X-ray crystallographic analysis of the ETS domain of human Ergp55 in complex with the cfos promoter DNA sequence.

Shanti P Gangwar1, Sita R Meena, Ajay K Saxena.   

Abstract

The Ergp55 protein belongs to the Ets family of transciption factors. The Ets transcription factors are involved in various developmental processes and the regulation of cancer metabolism. They contain a highly similar DNA-binding domain known as the ETS domain and have diverse functions in oncogenesis and physiology. The Ets transcription factors differ in their DNA-binding preference at the ETS site and the mechanisms by which they target genes are not clearly understood. To understand its DNA-binding mechanism, the ETS domain of Ergp55 was expressed and purified. The ETS domain was crystallized in the native form and in complex forms with DNA sequences from the E74 and cfos promoters. An X-ray diffraction data set was collected from an ETS-cfos DNA complex crystal at a wavelength of 0.9725 Å on the BM14 synchrotron beamline at the ESRF, France. The ETS-cfos DNA complex crystal belonged to space group C222(1), with four molecules in the asymmetric unit. For structure analysis, initial phases for the ETS-cfos DNA complex were obtained by the molecular-replacement technique with Phaser in the CCP4 suite using the coordinates of Fli-1 protein (PDB entry 1fli) and cfos DNA (PDB entry 1bc7) as search models. Structure analysis of the ETS-cfos DNA complex may possibly explain the DNA-binding specificity and its mechanism of interaction with the ETS domain of Ergp55.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143243      PMCID: PMC3515375          DOI: 10.1107/S1744309112038675

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  23 in total

1.  Structural studies of Ets-1/Pax5 complex formation on DNA.

Authors:  C W Garvie; J Hagman; C Wolberger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 2.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

3.  Structures of SAP-1 bound to DNA targets from the E74 and c-fos promoters: insights into DNA sequence discrimination by Ets proteins.

Authors:  Y Mo; B Vaessen; K Johnston; R Marmorstein
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 4.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks; A L Brown; Y Ling; P R Yates
Journal:  Int J Biochem Cell Biol       Date:  1997-12       Impact factor: 5.085

Review 5.  Ets transcription factors and human disease.

Authors:  J Dittmer; A Nordheim
Journal:  Biochim Biophys Acta       Date:  1998-04-17

6.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

7.  Solution structure of the ets domain of Fli-1 when bound to DNA.

Authors:  H Liang; X Mao; E T Olejniczak; D G Nettesheim; L Yu; R P Meadows; C B Thompson; S W Fesik
Journal:  Nat Struct Biol       Date:  1994-12

8.  Structural modeling and DNA binding autoinhibition analysis of Ergp55, a critical transcription factor in prostate cancer.

Authors:  Shanti P Gangwar; Sharmistha Dey; Ajay K Saxena
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

9.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.

Authors:  Ti Wen; Whitney Barham; Ying Li; Henan Zhang; Joanina K Gicobi; Jacob B Hirdler; Xin Liu; Hyoungjun Ham; Kodi E Peterson Martinez; Fabrice Lucien; Roxane R Lavoie; Hu Li; Cristina Correia; Dileep D Monie; Zesheng An; Susan M Harrington; Xiaosheng Wu; Ruifeng Guo; Roxana S Dronca; Aaron S Mansfield; Yiyi Yan; Svetomir N Markovic; Sean S Park; Jie Sun; Hong Qin; Minetta C Liu; George Vasmatzis; Daniel D Billadeau; Haidong Dong
Journal:  Cancer Immunol Res       Date:  2021-12-15       Impact factor: 11.151

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.